Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

Abstract Aims We aimed to assess the impact of pre‐admission beta‐blocker (BB) therapy on the clinical characteristics, in‐hospital treatment and outcomes of patients with cardiogenic shock (CS). Methods All patients enrolled in the multicentre prospective Altshock‐2 registry since March 2020 with a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, Altshock‐2 investigators
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2025-08-01
Col·lecció:	ESC Heart Failure
Matèries:	Cardiogenic shock beta‐blockers inotropes mortality vasopressors
Accés en línia:	https://doi.org/10.1002/ehf2.15322
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!